The Ides of March bring no mis­for­tune to biotech, as in­dus­try logs sec­ond-busiest IPO week of 2021

Ed­i­tor’s note: In­ter­est­ed in fol­low­ing bio­phar­ma’s fast-paced IPO mar­ket? You can book­mark our IPO Track­er here.

Af­ter a slow cou­ple of weeks, the biotech IPO mar­ket is heat­ing back up with four more com­pa­nies hit­ting Nas­daq.

In­stil Bio, Con­nect Bio­phar­ma, Finch Ther­a­peu­tics and Gain Ther­a­peu­tics are this week’s win­ners, with the fear­some four­some all mak­ing their pub­lic de­buts Thurs­day or Fri­day. In­stil led the way with a heav­i­ly up­sized $320 mil­lion raise, mark­ing the sec­ond-biggest IPO raise of 2021 be­hind Sana, and Con­nect and Finch al­so pulled in nine-fig­ure fund­ing.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER